BIOTECanada and BioTalent Canada Announce Partnership to Strengthen Canada's Bio-economy

Monday, June 17th, 2013

BIOTECanada and BioTalent Canada have signed a milestone agreement enabling these two national organizations to collaborate and help Canada’s bio-economy continue to be a key driver of Canada’s economy.  

[ Read more here ]

Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent

Thursday, June 13th, 2013

Therapure Biopharma Inc., a contract development and manufacturing organization (CDMO) of biotherapeutics, is pleased to announce the company will participate as a subcontractor for DynPort Vaccine Company LLC that was awarded a US cost-plus-fixed-fee contract with a maximum value of $157.3 million by the US Department of Defense (DoD) to support the development of a prophylactic countermeasure to prevent the effects of organophosphorus nerve agent poisoning.

[ Read more here ]

Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin Licensing Deals

Thursday, June 6th, 2013

Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) (Bioniche) and Paladin Labs Inc.(TSX: PLB) (Paladin) today announced a comprehensive strategic collaboration to refinance and increase Bioniches debt, provide new equity, and enter into the first licensing deal for Bioniches Phase III bladder cancer product Urocidin

[ Read more here ]

Rna Diagnostics selected to participate in EXCITE program to evaluate RDA

Friday, May 31st, 2013

Rna Diagnostics, Inc. (RnaDx) has been accepted into the MaRS Excellence in Clinical Innovation and Technology Evaluation (EXCITE) program for the clinical evaluation of their diagnostic test, RNA Disruption Assay™

[ Read more here ]

Nutrasource Diagnostics Inc. Acquires Diteba Research Laboratories Inc.

Friday, May 31st, 2013

Nutrasource Diagnostics Inc. (NDI) is pleased to announce that it has acquired the business assets of Diteba Research Laboratories Inc. (Diteba) of Mississauga, Ontario, Canada.

[ Read more here ]